M. JEFFREY FRANK, M.D.; NATHAN FRANK, M.D., F.A.C.P.
This content is PDF only. Please click on the PDF icon to access.
To the editor: To date a few pharmacologic agents have been found that effectively prevent the aggregation and reduce the "stickiness" of platelets: dipyridamole, Malayan cobra snake venom, and aspirin. To prove the efficacy of these drugs for prophylaxis of coronary artery thrombosis would require a trial of large numbers of patients over a period of several years. Valuable time lost! There is an indirect means that may help convince competent cardiac investigators that aspirin therapy is worthy for treatment of patients with potential or established ischemic heart disease due to coronary artery disease.
We suggest a study on this
Learn more about subscription options.
Register Now for a free account.
FRANK MJ, FRANK N. Prophylactic Aspirin?. Ann Intern Med. 1973;78:462. doi: 10.7326/0003-4819-78-3-462_2
Download citation file:
Published: Ann Intern Med. 1973;78(3):462.
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only